DFAI
Price
$38.45Alerts
Change
-$0.99 (-2.51%)
Updated
Nov 20 closing price
Net Assets
17.74B
Intraday BUY SELL Signals
NMR
Price
$8.51Alerts
Change
-$0.53 (-5.86%)
Updated
Nov 20 closing price
Capitalization
27.53B
73 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DFAI vs NMR

DFAI vs NMR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DFAI vs. NMR commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFAI is a Hold and NMR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for DFAI with price predictions
Nov 20, 2026

DFAI's Indicator enters downward trend

The Aroon Indicator for DFAI entered a downward trend on October 19, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 131 similar instances where the Aroon Indicator formed such a pattern. In 106 of the 131 cases the stock moved lower. This puts the odds of a downward move at 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DFAI as a result. In 66 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.

The Moving Average Convergence Divergence Histogram (MACD) for DFAI turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 35 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.

DFAI moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DFAI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +0.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where DFAI advanced for three days, in 273 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

DFAI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
a Summary for NMR with price predictions
Nov 20, 2026

NMR's Indicator enters downward trend

The Aroon Indicator for NMR entered a downward trend on November 03, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 138 similar instances where the Aroon Indicator formed such a pattern. In 89 of the 138 cases the stock moved lower. This puts the odds of a downward move at 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NMR as a result. In 43 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.

The Moving Average Convergence Divergence Histogram (MACD) for NMR turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 27 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for NMR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +3.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where NMR advanced for three days, in 206 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

NMR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. NMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.007) is normal, around the industry mean (3.143). P/E Ratio (0.068) is within average values for comparable stocks, (6.733). Projected Growth (PEG Ratio) (0.815) is also within normal values, averaging (0.809). Dividend Yield (0.041) settles around the average of (8.975) among similar stocks. P/S Ratio (2.472) is also within normal values, averaging (17.075).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
NMR: Fundamental Ratings
NMR
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
22
SMR RATING
1..100
1
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DFAINMR
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
65%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
53%
MACD
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
56%
Advances
ODDS (%)
Bullish Trend 25 days ago
82%
Bullish Trend 25 days ago
68%
Declines
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
54%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
64%
Aroon
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 3 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement

DFAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DFAI has been closely correlated with BBVA. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if DFAI jumps, then BBVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DFAI
1D Price
Change %
DFAI100%
-2.51%
BBVA - DFAI
75%
Closely correlated
-3.85%
SAN - DFAI
75%
Closely correlated
-2.37%
MT - DFAI
73%
Closely correlated
-6.17%
BHP - DFAI
71%
Closely correlated
-2.00%
NMR - DFAI
71%
Closely correlated
-5.86%
More

NMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NMR has been loosely correlated with MS. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NMR jumps, then MS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NMR
1D Price
Change %
NMR100%
-5.86%
MS - NMR
55%
Loosely correlated
-5.32%
GS - NMR
54%
Loosely correlated
-6.71%
MCO - NMR
49%
Loosely correlated
-0.85%
LAZ - NMR
49%
Loosely correlated
-5.32%
RJF - NMR
49%
Loosely correlated
-1.93%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EFSC58.13-0.88
-1.49%
Enterprise Financial Services Corp
HALO91.35-1.69
-1.82%
Halozyme Therapeutics
YB10.61-0.43
-3.89%
Yuanbao Inc
OKYO1.10-0.06
-5.17%
OKYO Pharma Limited
ISPC0.46-0.07
-13.58%
iSpecimen Inc.